1994
DOI: 10.5014/ajot.48.3.263
|View full text |Cite
|
Sign up to set email alerts
|

The Combined Intervention of Therapy and Bromocriptine Mesylate to Improve Functional Performance After Brain Injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1995
1995
2011
2011

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…It has been used to attenuate menstrual and fertility problems and to treat symptoms of Parkinson's disease. Previous clinical work has shown that bromocriptine combination treatment contributes to improved functional outcome after TBI [35,41]. In another study chronic bromocriptine treatment was shown to improve cognitive function and motivation after TBI [42].…”
Section: Neurotransmitter-based Posttraumatic Interventionsmentioning
confidence: 92%
“…It has been used to attenuate menstrual and fertility problems and to treat symptoms of Parkinson's disease. Previous clinical work has shown that bromocriptine combination treatment contributes to improved functional outcome after TBI [35,41]. In another study chronic bromocriptine treatment was shown to improve cognitive function and motivation after TBI [42].…”
Section: Neurotransmitter-based Posttraumatic Interventionsmentioning
confidence: 92%
“…Furthermore, a chronic and delayed administration paradigm of BRO enhances both working and reference memory [58]. Clinically, anecdotal reports have described functional improvement after TBI with BRO treatment, with or without occupational and physical therapy [59‐63]. In a small, double‐blind, placebo‐controlled crossover study, BRO treatment was reported to improve performance on clinical measures of executive function [64].…”
Section: Neurotransmitters and Plasticitymentioning
confidence: 99%
“…to t.i.d. with food and may be increased by 1.25 mg weekly to a maximal daily dose of 90 mg in three divided doses [11][12][13][14]. Arousal, attention and functional activities should be monitored closely.…”
Section: Bromocriptinementioning
confidence: 99%